Iteos Therapeutics Inc (ITOS)

10:47 AM

Iteos Therapeutics stock hits 52-week low at $7.58 - Investing.com India

10:47 AM

10:04 AM

Iteos Therapeutics stock hits 52-week low at $7.58 By Investing.com - Investing.com UK

10:04 AM

Nov 19, 2024

Insider Buying: Matthew Gall Acquires 5,000 Shares of ITeos Ther - GuruFocus.com

Nov 19, 2024

Nov 19, 2024

iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock By Investing.com - Investing.com UK

Nov 19, 2024

Nov 19, 2024

iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 19, 2024

Nov 16, 2024

Equities Analysts Offer Predictions for ITOS FY2024 Earnings - Defense World

Nov 16, 2024

Nov 16, 2024

US Bancorp DE Has $123,000 Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 16, 2024

Nov 15, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Simply Wall St

Nov 15, 2024

Nov 15, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

HC Wainwright Reaffirms Buy Rating for iTeos Therapeutics (NASDAQ:ITOS) - MarketBeat

Nov 15, 2024

Nov 15, 2024

EcoR1 Capital, LLC Reduces Stake in ITeos Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

FY2024 EPS Forecast for iTeos Therapeutics Lifted by Analyst - MarketBeat

Nov 15, 2024

Nov 14, 2024

Iteos Therapeutics stock hits 52-week low at $8.39 - Investing.com

Nov 14, 2024

Nov 14, 2024

Wedbush Reaffirms Outperform Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Nov 14, 2024

Nov 13, 2024

iTeos Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024

Nov 13, 2024

iTeos verkündet Finanzergebnisse für das dritte Quartal 2024 und gibt aktuelle Geschäftsinformationen bekannt - GlobeNewswire Inc.

Nov 13, 2024

Nov 12, 2024

Creative Planning Acquires 1,196 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 12, 2024

Nov 12, 2024

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

iTeos Reports Wider Q3 Loss, Maintains $684M Cash Runway Through 2027 | ITOS Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

iTeos Therapeutics Inc. (ITOS) Quarterly 10-Q Report - Quartz

Nov 12, 2024

Oct 31, 2024

Iteos Therapeutics stock hits 52-week low at $8.49 - Investing.com India

Oct 31, 2024

Oct 30, 2024

Iteos Therapeutics stock hits 52-week low at $8.49 By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 24, 2024

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress - GlobeNewswire

Oct 24, 2024

Oct 24, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by nVerses Capital LLC - Defense World

Oct 24, 2024

Oct 23, 2024

Iteos Therapeutics stock hits 52-week low at $8.73 - Investing.com India

Oct 23, 2024

Oct 23, 2024

Iteos Therapeutics stock hits 52-week low at $8.73 By Investing.com - Investing.com Canada

Oct 23, 2024

Oct 23, 2024

Exchange Traded Concepts LLC Sells 6,414 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 23, 2024

Oct 22, 2024

(ITOS) Proactive Strategies - Stock Traders Daily

Oct 22, 2024

Oct 16, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Position Decreased by AQR Capital Management LLC - MarketBeat

Oct 16, 2024

Oct 16, 2024

BOXER CAPITAL, LLC Expands Stake in ITeos Therapeutics Inc - GuruFocus.com

Oct 16, 2024

Oct 15, 2024

ITeos Therapeutics Inc (ITOS) shows promising results - US Post News

Oct 15, 2024

Oct 15, 2024

Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 9.73, Down by -2.21 - The Dwinnex

Oct 15, 2024

Oct 14, 2024

ITOS Stock on the Rise: A Promising Investment - The InvestChronicle

Oct 14, 2024

Oct 14, 2024

Millennium Management LLC Decreases Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 14, 2024

Oct 14, 2024

Millennium Management LLC Lowers Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Oct 14, 2024

Oct 12, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Update - Defense World

Oct 12, 2024

Oct 12, 2024

Squarepoint Ops LLC Sells 38,801 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 12, 2024

Oct 11, 2024

When (ITOS) Moves Investors should Listen - Stock Traders Daily

Oct 11, 2024

Oct 11, 2024

Did ITeos Therapeutics Inc (ITOS) perform well in the last session? - US Post News

Oct 11, 2024

Oct 11, 2024

Ratio Revelations: ITeos Therapeutics Inc (ITOS)’s Financial Metrics in the Spotlight - The Dwinnex

Oct 11, 2024

Oct 07, 2024

TIGITs Trend Upward After iTeos/GSK Present Positive Data at ESMO - BioSpace

Oct 07, 2024

Oct 06, 2024

Dimensional Fund Advisors LP Raises Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Oct 06, 2024

Oct 04, 2024

ITeos TherapeuticsAssessing Breakthrough Therapies To Treat Cancer - RTTNews

Oct 04, 2024

Oct 03, 2024

A new trading data show ITeos Therapeutics Inc (ITOS) is showing positive returns. - SETE News

Oct 03, 2024

Oct 03, 2024

American Century Companies Inc. Has $687,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Oct 03, 2024

Oct 01, 2024

A closer look at ITeos Therapeutics Inc (ITOS)’s stock price trends - US Post News

Oct 01, 2024

Oct 01, 2024

Financial Metrics Exploration: Understanding ITeos Therapeutics Inc (ITOS) Through Ratios - The Dwinnex

Oct 01, 2024

Oct 01, 2024

How the (ITOS) price action is used to our Advantage - Stock Traders Daily

Oct 01, 2024

Sep 30, 2024

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in ITeos Therapeu - GuruFocus.com

Sep 30, 2024

Sep 29, 2024

156,894 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Bought by Clearline Capital LP - Defense World

Sep 29, 2024

Sep 29, 2024

Clearline Capital LP Invests $2.33 Million in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Sep 29, 2024

Sep 26, 2024

There is no way ITeos Therapeutics Inc (ITOS) can keep these numbers up - SETE News

Sep 26, 2024

Sep 25, 2024

ESMO recap: Keeping TIGIT alive, Rybrevant & immunotherapy anniversary — a BioCentury podcast - BioCentury

Sep 25, 2024

Sep 25, 2024

ITeos Therapeutics Inc (ITOS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Sep 25, 2024

Sep 25, 2024

Renaissance Technologies LLC Sells 157,700 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Sep 25, 2024

Sep 25, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Rhumbline Advisers - Defense World

Sep 25, 2024

Sep 25, 2024

Renaissance Technologies LLC Has $8.30 Million Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Sep 25, 2024

Sep 23, 2024

Analytical Lens: Exploring ITeos Therapeutics Inc (ITOS)’s Financial Story Through Ratios - The Dwinnex

Sep 23, 2024

Sep 22, 2024

The week in pharma: action, reaction and insight – week to September 2024 | Pharmaceutical | The Pharmaletter - The Pharma Letter

Sep 22, 2024